Aquestive Therapeutics (AQST) Research Hub

Aquestive Therapeutics (AQST) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 3.97 USD (-0.75%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.46, market cap 0.39B. This hub links to the full technical, earnings and options research available for AQST.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Drug Manufacturers - Specialty & Generic)
ExchangeNASDAQ, US
Last close3.97 USD (-0.75%)
52-week range3.56 USD – 5.49 USD
Trend regimeRange
14-day RSI31.6 (Bearish)
Trailing P/E-6.46
Market cap0.39B
Dividend yield0.00%
Next earnings2026-08-10

Available research for AQST

Earnings

AQST earnings date and last-quarter result: next report 2026-08-10, last quarter miss, P/E -6.46. Updated 2026-07-23.

Options: Covered Call

Covered Call on AQST: how it works, illustrative setup around the real 3.97 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on AQST: how it works, illustrative setup around the real 3.97 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on AQST: how it works, illustrative setup around the real 3.97 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

AQST technical analysis: range, last 3.97 USD, RSI 31.6, 52w range 3.56 USD–5.49 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is AQST in?

Aquestive Therapeutics (AQST) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.

Is AQST in an uptrend or downtrend?

As of 2026-10-26, AQST is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is AQST's trailing P/E ratio?

AQST's trailing P/E is -6.46, with a market cap of 0.39B. See the earnings research page for full valuation detail.

When does AQST next report earnings?

AQST is next scheduled to report earnings on 2026-08-10.